{"id":545481,"date":"2021-05-31T13:52:01","date_gmt":"2021-05-31T13:52:01","guid":{"rendered":"https:\/\/www.abnewswire.com\/pressreleases\/?p=545481"},"modified":"2021-05-31T13:52:01","modified_gmt":"2021-05-31T13:52:01","slug":"celiac-disease-market-insights-epidemiology-and-market-forecast-by-delveinsight","status":"publish","type":"post","link":"https:\/\/www.abnewswire.com\/pressreleases\/celiac-disease-market-insights-epidemiology-and-market-forecast-by-delveinsight_545481.html","title":{"rendered":"Celiac Disease Market Insights, Epidemiology and Market Forecast by DelveInsight"},"content":{"rendered":"<div style=\"float:right;  width:250px; padding:8px 10px 10px 10px;\"><a href=\"https:\/\/www.abnewswire.com\/uploads\/1622445877.png\" style=\"border:none !important;\" target=\"_blank\" rel=\"nofollow\" ><img loading=\"lazy\" decoding=\"async\" class=\"alignnone size-medium wp-image-29\" title=\"Celiac Disease Market Insights, Epidemiology and Market Forecast by DelveInsight\" src=\"https:\/\/www.abnewswire.com\/uploads\/1622445877.png\" alt=\"Celiac Disease Market Insights, Epidemiology and Market Forecast by DelveInsight\" width=\"225\" height=\"225\" \/><\/a><\/div>\n<p style=\"text-align: justify;\"><strong>&ldquo;<span style=\"text-decoration: underline;\"><a rel=\"nofollow\" href=\"https:\/\/www.delveinsight.com\/report-store\/celiac-disease-cd-market?utm_source=SatPR&amp;utm_medium=pressrelease&amp;utm_campaign=ypr\" target=\"_blank\">Celiac Disease Market<\/a><\/span><\/strong>&rdquo; has been added to DelveInsight<\/p>\n<p style=\"text-align: justify;\">&nbsp;<\/p>\n<p style=\"text-align: justify;\"><strong>Celiac Disease Overview<\/strong><\/p>\n<p style=\"text-align: justify;\">Chronic kidney disease&nbsp;(CKD) is a syndrome where there are persistent alterations in kidney structure, function, or both with implications on the health of the individual. Examples of structural abnormalities include cysts, tumors, malformations and atrophy, which are evident on imaging. By contrast, kidney dysfunction can manifest as hypertension, edema, and changes in output or quality of urine and growth delay in children. These changes are most often recognized by increased serum levels of creatinine, cystatin C, or blood urea nitrogen. Moreover, the most common pathological manifestation of CKD, regardless of the initiating insult or disease, is some form of renal fibrosis.<\/p>\n<p style=\"text-align: justify;\">&nbsp;<\/p>\n<p style=\"text-align: justify;\"><strong>Celiac Disease Market Insights<\/strong><\/p>\n<p style=\"text-align: justify;\">DelveInsight&rsquo;s&nbsp;&lsquo;Celiac Disease Market Insights, Epidemiology and Market Forecast&ndash; 2030&rsquo;&nbsp;report delivers an in-depth understanding of the Celiac Disease (CD), historical and forecasted epidemiology as well as the Celiac Disease (CD) market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.<\/p>\n<p style=\"text-align: justify;\">&nbsp;<strong>Get a free Celiac Disease report sample page-&nbsp;<span style=\"text-decoration: underline;\"><a rel=\"nofollow\" href=\"https:\/\/www.delveinsight.com\/sample-request\/celiac-disease-cd-market?utm_source=SatPR&amp;utm_medium=pressrelease&amp;utm_campaign=ypr\" target=\"_blank\">https:\/\/www.delveinsight.com\/sample-request\/celiac-disease-cd-market<\/a><\/span><\/strong><\/p>\n<p style=\"text-align: justify;\">&nbsp;<\/p>\n<p style=\"text-align: justify;\"><strong>Celiac Disease Market: Regions Covered<\/strong><\/p>\n<ul style=\"text-align: justify;\">\n<li>The United States<\/li>\n<li>EU5 (Germany, France, Italy, Spain, and the United Kingdom)<\/li>\n<li>Japan<\/li>\n<\/ul>\n<p style=\"text-align: justify;\">&nbsp;<\/p>\n<p style=\"text-align: justify;\"><strong>Celiac Disease Market Report&nbsp;<\/strong><\/p>\n<ul style=\"text-align: justify;\">\n<li>Research Analysis<\/li>\n<li>Market Analysis<\/li>\n<li>Pipeline Valuation<\/li>\n<li>Market Size by therapies<\/li>\n<li>Market Share by therapies<\/li>\n<\/ul>\n<p style=\"text-align: justify;\">&nbsp;<\/p>\n<p style=\"text-align: justify;\"><strong>Celiac Disease Treatment<\/strong><\/p>\n<p style=\"text-align: justify;\">Chronic kidney disease (CKD) is a type of kidney disease in which there is a gradual loss of kidney function over a period of months to years. The initial symptoms include leg swelling, feeling tired, vomiting, loss of appetite, and confusion; complications in CKD involve anemia, bone disease, high blood pressure and increased risk of heart disease. Anemia is common and is especially prevalent in those requiring hemodialysis. The mechanism of anemia in CKD are multifactorial and include increased inflammation, reduction in erythropoietin, and hyperuricemia leading to bone marrow suppression. There are different types of medications available in the market. Available medicines cannot reverse CKD; however, they are used to treat complications and to slow further kidney damage.<\/p>\n<p style=\"text-align: justify;\">&nbsp;<\/p>\n<p style=\"text-align: justify;\"><strong>Celiac Disease Market: Key Players<\/strong><\/p>\n<ul style=\"text-align: justify;\">\n<li>GlaxoSmithKline<\/li>\n<li>Akebia Therapeutics<\/li>\n<li>AstraZeneca<\/li>\n<li>Chong Kun Dang Pharmaceuticals<\/li>\n<\/ul>\n<p style=\"text-align: justify;\">&nbsp;<\/p>\n<p style=\"text-align: justify;\"><strong>Celiac Disease Market: Drugs<\/strong><\/p>\n<ul style=\"text-align: justify;\">\n<li>Latiglutenase<\/li>\n<li>Larazotide<\/li>\n<\/ul>\n<p style=\"text-align: justify;\">&nbsp;<\/p>\n<p style=\"text-align: justify;\"><strong>Celiac Disease Market Size<\/strong><\/p>\n<p style=\"text-align: justify;\">The increase in market size is a direct consequence of increasing prevalent population of Chronic Kidney Disease (CKD) patients in the 7MM, along with the expected entry of premium price asset such Anti-inflammatories, Prolyl hydroxylase and IL-6 inhibitors, which will have a significant impact on the market size. The market size of Chronic Kidney Disease (CKD) is anticipated to increase during the study period, 2017&ndash;2030.<\/p>\n<p style=\"text-align: justify;\">&nbsp;<\/p>\n<p style=\"text-align: justify;\"><strong>Celiac Disease Market Insights<\/strong><\/p>\n<p style=\"text-align: justify;\">Chronic kidney disease (CKD) is a type of kidney disease in which there is a gradual loss of kidney function over a period of months to years. The initial symptoms include leg swelling, feeling tired, vomiting, loss of appetite, and confusion; complications in CKD involve anemia, bone disease, high blood pressure and increased risk of heart disease. Anemia is common and is especially prevalent in those requiring hemodialysis. The mechanism of anemia in CKD are multifactorial and include increased inflammation, reduction in erythropoietin, and hyperuricemia leading to bone marrow suppression.<\/p>\n<p style=\"text-align: justify;\">&nbsp;<\/p>\n<p style=\"text-align: justify;\">&nbsp;<\/p>\n<p style=\"text-align: justify;\"><strong>Table of content<\/strong><\/p>\n<p style=\"text-align: justify;\"><strong>1&nbsp;<\/strong>Key Insights<\/p>\n<p style=\"text-align: justify;\">2 Celiac Disease Market Overview at a Glance<\/p>\n<p style=\"text-align: justify;\">3 Executive Summary of Celiac Disease (CD)<\/p>\n<p style=\"text-align: justify;\">4 Disease Background and Overview: Celiac Disease<\/p>\n<p style=\"text-align: justify;\">5 Algorithm for Diagnosis of CD<\/p>\n<p style=\"text-align: justify;\">6 Diagnostic Guidelines by the European Society for the Study of Coeliac Disease (ESsCD)<\/p>\n<p style=\"text-align: justify;\">7 Diagnostic Guidelines by the World Gastroenterology Organization (WGO)<\/p>\n<p style=\"text-align: justify;\">8 Epidemiology and Patient Population: Key Findings<\/p>\n<p style=\"text-align: justify;\">9 Country Wise-Epidemiology of Celiac Disease<\/p>\n<p style=\"text-align: justify;\">10 Treatment<\/p>\n<p style=\"text-align: justify;\">11 Treatment Algorithm for CD<\/p>\n<p style=\"text-align: justify;\">12 Treatment Algorithm for CD by BMJ Best Practice<\/p>\n<p style=\"text-align: justify;\">13 European Society for the Study of Coeliac Disease (ESsCD) guideline for coeliac disease and other gluten-related disorders<\/p>\n<p style=\"text-align: justify;\">14 World Gastroenterology Organisation Global Guidelines for CD<\/p>\n<p style=\"text-align: justify;\">15 Recognized Establishments<\/p>\n<p style=\"text-align: justify;\">16 Unmet Needs<\/p>\n<p style=\"text-align: justify;\">17 Emerging Drugs<\/p>\n<p style=\"text-align: justify;\">18 Celiac Disease: 7 Major Market Analysis<\/p>\n<p style=\"text-align: justify;\">19 The United States Market Outlook<\/p>\n<p style=\"text-align: justify;\">20 EU-5 Countries: Market Outlook<\/p>\n<p style=\"text-align: justify;\">21 Japan Market Outlook<\/p>\n<p style=\"text-align: justify;\">22 KOL Reviews<\/p>\n<p style=\"text-align: justify;\">23 Case Reports<\/p>\n<p style=\"text-align: justify;\">24 Market Drivers<\/p>\n<p style=\"text-align: justify;\">25 Market Barriers<\/p>\n<p style=\"text-align: justify;\">26 SWOT Analysis<\/p>\n<p style=\"text-align: justify;\">27 Appendix<\/p>\n<p style=\"text-align: justify;\">28&nbsp;<strong>DelveInsight<\/strong>&nbsp;Capabilities<\/p>\n<p style=\"text-align: justify;\">29 Disclaimer<\/p>\n<p style=\"text-align: justify;\">30 About&nbsp;<strong>DelveInsight<\/strong><\/p>\n<p style=\"text-align: justify;\">&nbsp;<\/p>\n<p style=\"text-align: justify;\"><strong>Why should you buy this report?<\/strong><\/p>\n<ul style=\"text-align: justify;\">\n<li>The report will help in creating business methodologies by understanding patterns forming and driving the&nbsp;<strong>Celiac Disease<\/strong>&nbsp;market<\/li>\n<li>To comprehend the future market rivalry in the&nbsp;<strong>Celiac Disease<\/strong>&nbsp;market and Insightful survey of the key market drivers and hindrances<\/li>\n<li>Sort out deals and promoting endeavors by recognizing the best open doors for&nbsp;<strong>Celiac Disease<\/strong>&nbsp;in the US, Europe (Germany, Spain, Italy, France, and the United Kingdom) and Japan<\/li>\n<li>ID of solid impending parts in the market will help in formulating procedures that will help in advancing beyond contenders<\/li>\n<li>Coordinate deals and showcasing endeavors by recognizing the best open doors for&nbsp;<strong>Celiac Disease<\/strong>&nbsp;market<\/li>\n<li>To comprehend the future market rivalry in the&nbsp;<strong>Celiac Disease<\/strong>&nbsp;market<\/li>\n<\/ul>\n<p style=\"text-align: justify;\">&nbsp;<\/p>\n<p style=\"text-align: justify;\"><strong>You can check our related reports-<\/strong><\/p>\n<ul style=\"text-align: justify;\">\n<li><a rel=\"nofollow\" href=\"https:\/\/www.delveinsight.com\/report-store\/celiac-disease-cd-epidemiology-forecast\"><strong>Celiac Disease Epidemiology<\/strong><\/a>.<\/li>\n<li><a rel=\"nofollow\" href=\"https:\/\/www.delveinsight.com\/report-store\/celiac-disease-pipeline-insight\"><strong>Celiac Disease Pipeline<\/strong><\/a><\/li>\n<\/ul>\n<p style=\"text-align: justify;\"><strong>&nbsp;<\/strong><\/p>\n<p style=\"text-align: justify;\"><strong>About Us<\/strong><\/p>\n<div class=\"col-lg-12 col-md-12 col-sm-12 col-xs-12 widget w-info\" style=\"text-align: justify;\">\n<p class=\"c-white fs-12 mb-20\">DelveInsight is a Business Consulting and Market research company, providing expert business solutions for life science vertical and offering quintessential advisory services in the areas of R&amp;D, Strategy Formulation, Operations, Competitive Intelligence, Competitive Landscaping, and Mergers &amp; Acquisitions.<\/p>\n<\/div>\n<div class=\"col-lg-12 col-md-12 col-sm-12 col-xs-12\" style=\"text-align: justify;\">&nbsp;<\/div>\n<div class=\"col-lg-12 col-md-12 col-sm-12 col-xs-12\" style=\"text-align: justify;\">&nbsp;<\/div>\n<p><span style='font-size:18px !important;'>Media Contact<\/span><br \/><strong>Company Name:<\/strong> <a href=\"https:\/\/www.abnewswire.com\/companyname\/delveinsight.com_56402.html\" rel=\"nofollow\">DelveInsight Business Research LLP<\/a><br \/><strong>Contact Person:<\/strong> Yash Bhardwaj<br \/><strong>Email:<\/strong> <a href=\"https:\/\/www.abnewswire.com\/email_contact_us.php?pr=celiac-disease-market-insights-epidemiology-and-market-forecast-by-delveinsight\" rel=\"nofollow\">Send Email<\/a><br \/><strong>Phone:<\/strong> +919650213330<br \/><strong>Address:<\/strong>304 S. Jones Blvd #2432  <br \/><strong>City:<\/strong> Las Vegas<br \/><strong>State:<\/strong> NV<br \/><strong>Country:<\/strong> United States<br \/><strong>Website:<\/strong> <a href=\"https:\/\/www.delveinsight.com\/\" target=\"_blank\" rel=\"nofollow\">https:\/\/www.delveinsight.com\/<\/a><\/p>\n<p><object type=\"text\/html\" data=\"https:\/\/www.delveinsight.com\/\" style=\"width:900px; height:400px;\"><\/object><img decoding=\"async\" src=\"https:\/\/www.abnewswire.com\/press_stat.php?pr=celiac-disease-market-insights-epidemiology-and-market-forecast-by-delveinsight\" alt=\"\" width=\"1px\" height=\"1px\" \/><\/p>\n","protected":false},"excerpt":{"rendered":"<p>&ldquo;Celiac Disease Market&rdquo; has been added to DelveInsight &nbsp; Celiac Disease Overview Chronic kidney disease&nbsp;(CKD) is a syndrome where there are persistent alterations in kidney structure, function, or both with implications on the health of the individual. Examples of structural &hellip; <a href=\"https:\/\/www.abnewswire.com\/pressreleases\/celiac-disease-market-insights-epidemiology-and-market-forecast-by-delveinsight_545481.html\">Continue reading <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[405,406,423,413],"tags":[],"class_list":["post-545481","post","type-post","status-publish","format-standard","hentry","category-Health-Medicine","category-Pharmaceuticals-Biotech","category-Professional-Services","category-Services"],"_links":{"self":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/545481","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/comments?post=545481"}],"version-history":[{"count":0,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/545481\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/media?parent=545481"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/categories?post=545481"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/tags?post=545481"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}